Support cells in glioblastoma tumors are linked to worse outcomes
Original title: Pericyte-Derived Cancer-Associated Fibroblasts Correlate with Poor Survival and Are Enriched After Chemoradiotherapy in Glioblastoma
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was a study of gene data from tumor samples, not a treatment tested in people.
The short version
Scientists studied a type of support cell inside glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary tumors and found that having more of them was linked to shorter survival.
What was studied. Researchers looked at gene activity data from brain tumors. They studied 54 single cell datasets and 88 bulk tissue samples to find out what these support cells are and where they come from.
What they found. The support cells, called cancer associated fibroblasts, appear to come from cells that wrap around blood vessels. Tumors with more of these cells were linked to shorter overall survival and a shorter time before the tumor grew again. These cells were also more common in IDH wildtype gliomas and in tumors sampled after chemotherapy and radiation.
What this means, and what it doesn't
What it could mean: This helps explain part of why some glioblastomas are harder to treat. If these cells help the tumor adapt after treatment, they could become a target for future research. Nothing about your care changes today.
What it doesn't mean: This does not mean there is a new treatment. No drug was tested in people or in animals here. The work was done by studying gene data from tumor samples that were already collected. It does not mean these cells can be removed or blocked. It is not a promise of a cure.
Source: bioRxiv (preprint), July 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.